Fast Forward - 11 September 2012

In September 2002 the National Asthma Reference Group (NARG) advising the Department of Health and Ageing was calling for decisive action to curb the over-prescribing of high dose inhaled corticosteroids (ICS).

Then-chair of NARG, Professor Christine Jenkins, told MO at the time that “far more radical proposals than merely promoting dissemination of information” were required.

This followed warnings from thoracic physicians of a potential epidemic of steroid-induced complications if prescribers failed to back-titrate medication or take account of the potency of products. Too many patients